Valproate in Bipolar Disorder: Case Examples From a Family Practice
- PMID: 15014688
- PMCID: PMC181065
- DOI: 10.4088/pcc.v01n0303
Valproate in Bipolar Disorder: Case Examples From a Family Practice
Abstract
Valproate, an antiepileptic drug, is useful in the management of various nonepileptic disorders. It is an effective and generally well-tolerated medication for the treatment of bipolar disorder and has been approved by the Food and Drug Administration for use in manic states. Studies also suggest that it is effective in other bipolar spectrum illnesses. This report describes 2 clinical cases of DSM-IV bipolar disorder where valproate provided robust, sustained relief of mood symptoms. In the first case, valproate was chosen for initial therapy in a bipolar patient suffering from a mixture of hypomanic and depressive symptoms. In the second case, valproate replaced lithium in the management of a patient with an incomplete response to lithium plus an antidepressant. This report addresses relevant clinical issues and includes a brief review of the clinical pharmacology of valproate.
Similar articles
-
[Guidelines for the prescription of mood stabilizers for adolescents: A literature review].Encephale. 2017 Oct;43(5):464-470. doi: 10.1016/j.encep.2016.09.005. Epub 2016 Nov 18. Encephale. 2017. PMID: 27871720 Review. French.
-
Bipolar II disorder : epidemiology, diagnosis and management.CNS Drugs. 2007;21(9):727-40. doi: 10.2165/00023210-200721090-00003. CNS Drugs. 2007. PMID: 17696573 Review.
-
Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.Arch Gen Psychiatry. 2005 Jan;62(1):37-45. doi: 10.1001/archpsyc.62.1.37. Arch Gen Psychiatry. 2005. PMID: 15630071 Clinical Trial.
-
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders.J Affect Disord. 2000 Sep;59 Suppl 1:S5-S30. doi: 10.1016/s0165-0327(00)00203-2. J Affect Disord. 2000. PMID: 11121824 Review.
-
Spotlight on lamotrigine in bipolar disorder.CNS Drugs. 2004;18(1):63-7. doi: 10.2165/00023210-200418010-00007. CNS Drugs. 2004. PMID: 14731061
Cited by
-
From Evidence to Practice: A Comprehensive Analysis of Side Effects in Synthetic Anti-Depressant Therapy.Curr Drug Saf. 2025;20(2):120-147. doi: 10.2174/0115748863301630240417071353. Curr Drug Saf. 2025. PMID: 38676478 Review.
References
-
- Lambert PA, Cavaz G, Borselli S, et al. Action neuro-psychotrope d'un nouvel antiepileptique: Le depamide. Ann Med Psychol. 1966;1:707–710. - PubMed
-
- Fawcett J. Valproate use in acute mania and bipolar disorder: an international perspective. J Clin Psychiatry. 1989;50(3, suppl):10–12. - PubMed
-
- McElroy SL, Keck PE, Pope HG. Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol. 1987;7:16–24. - PubMed
-
- McElroy SL, Keck PE Jr, Pope HG Jr, et al. Valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry. 1989;50(3, suppl):23–29. - PubMed
-
- Bowden CL, Brugger AM, Swan AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA. 1994;271:918–924. - PubMed
LinkOut - more resources
Full Text Sources